Safety of trifluridine/tipiracil in an open-label expanded-access program in elderly and younger patients with metastatic colorectal cancer

Mayer, RJ; Hochster, HS; Cohen, SJ; Winkler, R; Makris, L; Grothey, A

Mayer, RJ (reprint author), Dana Farber Canc Inst, 450 Brookline Ave, Boston, MA 02115 USA.

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018; 82 (6): 961

Abstract

PurposeTrifluridine/tipiracil (FTD/TPI; TAS-102, Lonsurf (R)), a novel form of chemotherapy for metastatic colorectal cancer (mCRC), has shown clinica......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索